Sun Pharmaceutical Industries Limited (Sun Pharma) and Philogen S.p.A. (Philogen) have entered an exclusive global commercialisation, licensing, and supply agreement for Fibromun (L19TNF), an advanced anti-cancer immunotherapy.
Read MoreSubscribe to our newsletter to get updates on our latest news